Publication | Closed Access

Efficient protective immunity against Trypanosoma cruzi infection after nasal vaccination with recombinant Sendai virus vector expressing amastigote surface protein-2

VaccinationNasal VaccinationMucosal VaccinationVaccine DevelopmentAfrican TrypanosomiasisTrypanosoma Cruzi InfectionImmunologyVirologyAmastigote Surface Protein-2Vaccine DesignMedicineViral Immunity